GSC
NGNE icon

Ground Swell Capital’s Neurogene NGNE Stock Holding History

Ground Swell Capital’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-35
Closed -$7K – 2643
2014
Q2 		$7K Buy
+35
New +$6.75K 0.01% 901

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Ground Swell Capital's NGNE Position: Q3 2014 in Review

Ground Swell Capital sold out of Neurogene (NGNE) in Q3 2014, closing a stake of 35 shares — an estimated $7K sold.

Ground Swell Capital first reported a position in NGNE in Q2 2014 and held it in 1 quarter. The position peaked at $7K in Q2 2014. 22 funds tracked by Wall St. Rank hold NGNE as of Q3 2014.

  • Ground Swell Capital reported no remaining Neurogene position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 35 Neurogene shares in Q3 2014, an estimated $7K.
  • Ground Swell Capital first reported a position in Neurogene in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's Neurogene position peaked at $7K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Neurogene as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.